Possible Involvement of p38 in Mechanisms Underlying Acceleration of Proliferation by 15-Deoxy-Δ12,14-prostaglandin J2 and the Precursors in Leukemia Cell Line THP-1

Journal of Pharmacological Sciences

Volumn 94, Issue 3, 2004, Pages 261-270

  Azuma, Yasutaka ^a   Watanabe, Kyoko ^a   Date, Masataka ^a   Daito, Michiharu ^a   Ohura, Kiyoshi ^a  

^a OSAKA DENTAL UNIVERSITY   (Japan)

Author keywords

15 deoxy 12,14 prostaglandin J 2; p38; Proliferation; Prostaglandin D2; THP 1

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN D2; PROTEIN P18; PROTEIN P21; PROTEIN P27;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EVALUATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INCUBATION TIME; INTERMETHOD COMPARISON; LEUKEMIA CELL; MITOSIS INHIBITION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR INTRINSIC ACTIVITY;

EID: 1842631751     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.94.261     Document Type: Article

References (38)

1. 2 is a ligand for the adipocyte determination factor PPARγ. Cell. 1995;83:803-812.
2. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell. 1995;83:813-819.
3. Kliewer SA, Sundseth SS, Jones SA, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptor α and γ. Proc Natl Acad Sci USA. 1997;94:4318-4323.
4. Sato H, Ishikawa S, Kawashima K, et al. Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists. Br J Cancer. 2000;83:1394-1400.
5. Tsubouchi Y, Sano H, Kawahito Y, et al. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-γ agonists through induction of apoptosis. Biochem Biophys Res Commun. 2000;270:400-405.
6. Avis I, Hong SH, Martinez A, et al. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J. 2000;15:2007-2009.
7. Yang WL, Frucht H. Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis. 2001;22:1379-1383.
8. Eibl G, Wente MN, Reber, HA, Hines OJ. Peroxisome proliferator-activated receptor γ induces pancreatic cancer cell apoptosis. Biochem Biophys Res Commun. 2001;287:522-529.
9. Guan YF, Zhang YH, Breyer RM, Davis L, Breyer MD. Expression of peroxisome proliferator-activated receptor γ (PPARgamma) in human transitional bladder cancer, and its role in inducing cell death. Neoplasia. 1999;1:330-339.
10. Gastri-Takahashi N, Okumura T, Motomura W, Fujimoto Y, Kawabata I, Kohgo Y. Activation of PPARgamma inhibits cell growth, and induces apoptosis in human gastric cancer cells. FEBS Lett. 1999;455:135-139.
11. Ohta K, Endo T, Haraguchi K, Hershman JM, Onaya T. Ligands for peroxisome proliferator-activated receptor-γ inhibit growth, and induce apoptosis of human papillary thyroid carcinoma cells. J Clin Endocrinol Metab. 2001;86:2170-2177.
12. 2 but not troglitazone. J Dent Res. 2003;82:802-806.
13. 2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. Can Res. 1999;59:2739-2746.
14. 2 induce diverse biological response via PPAR gamma activation in cancer cells. Prostaglandins Other Lipid Mediat. 2000;62:23-32.
15. Azuma Y, Ohura K. Alteration of constitutive apoptosis in neutrophils by quinolones. Inflammation. 2003;27:123-130.
16. Azuma Y, Ohura K. Endomorphin-2 modulates productions of TNF-α, IL-1β, IL-10 and IL-12, and alters functions related to innate immune of macrophages. Inflammation. 2002;26:223-232.
17. Azuma Y, Ohura K, Wang PL, Shinohara M. Endomorphins delay constitutive apoptosis and alter the innate host defense functions of neutrophils. Immunol Lett. 2002;81:31-40.
18. Buchdunger E, O'Reilly T, Wood J. Pharmacology of imatinib (STI571). Eur J Cancer. 2002;38:S28-S36.
19. Utsugi M, Dobashi K, Koga Y, et al. Ambroxol inhibits platelet-derived growth factor production in human monocytic cells. Eur J Pharmacol. 2002;436:47-51.
20. 1 induces peroxisome proliferator-activated receptor γ1 and γ2 expression in human THP-1 monocytes. Biochem Biophys Res Commun. 2002;297:794-799.
21. 2 derivatives really playing the part? Cell Signal. 2002;14:573-583.
22. Han S, Sidell N. Peroxisome-proliferator-activated-receptor gamma (PPARγ) independent induction of CD36 in THP-1 monocytes by retinoic acid. Immunol. 2002;106:53-59.
23. 2 and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor γ-independent mechanisms involving reactive oxygenated species. J Biol Chem. 2002;33:29681-29685.
24. Kondo M, Oya-Ito T, Kumagai T, Osawa T, Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J Biol Chem. 2001;276:12076-12083.
25. 2 induces apoptosis of human hepatic myofibroblasts. J Biol Chem. 2001;276:38152-38158.
26. 2 regulates mesangial cell proliferation and death. Kidney Int. 2002;61:1293-1302.
27. 2 receptors. J Cell Physiol. 2003;195:421-427.
28. Nerve RN, Holbro T, Hynes NE. District roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells. Oncogene. 2002;21:4567-4576.
29. Wang S, Nath N, Minden A, Chellappan S. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J. 1999;18:1559-1570.
30. Hou ST, Xie X, Baggley A, Park DS, Chen G, Walker T. Activation of the Rb/E2F1 pathway by the nonproliferative p38 MAPK during FAS (APO1/CD95) -mediated neuronal apoptosis. J Biol Chem. 2002;277:48764-48770.
31. 2 checkpoint. Oncogene. 2002;21;8089-8104.
32. Cip1 by phosphorylation. J Biol Chem. 2002;277:29792-29802.
33. Kim JY, Choi JA, Kim TH, et al. Involvment of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. J Cell Physiol. 2002;190:29-37.
34. MAPK pathway. J Biol Chem. 1996;271:20608-20616.
35. Page K, Li J, Hershenson MB. p38 MAP kinase negatively regulates cyclin D1 expression in airway smooth muscle cells. Am J Physiol. 2001;280:L955-L964.
36. Mullally JE, Moos PJ, Edes K, Fitzpatrick FA. Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteosome pathway. J Biol Chem. 2001;276:30366-30373.
37. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999;56:698-701.
38. 2 in human urine. J Biol Chem. 1988;263:16619-16625.